对ARYA Sciences收购Corp V（纳斯达克股票代码：ARYE）的空头利率下降了36.2％

ARYA Sciences Acquisition Corp V (NASDAQ:ARYE – Get Rating) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 3,700 shares, a decrease of 36.2% from the January 15th total of 5,800 shares. Approximately 0.0% of the company's shares are sold short. Based on an average trading volume of 58,900 shares, the days-to-cover ratio is presently 0.1 days.

ARYA Sciences Acquisition Corp V Price Performance

ARYA Sciences Acquisition Corp V stock traded up $0.01 during mid-day trading on Monday, reaching $10.12. 11,957 shares of the company's stock were exchanged, compared to its average volume of 110,723. ARYA Sciences Acquisition Corp V has a twelve month low of $9.62 and a twelve month high of $10.15. The company has a fifty day moving average of $10.06 and a 200-day moving average of $9.93.

Institutional Investors Weigh In On ARYA Sciences Acquisition Corp V

A number of hedge funds have recently added to or reduced their stakes in ARYE. Aristeia Capital LLC acquired a new stake in ARYA Sciences Acquisition Corp V during the 3rd quarter worth approximately $7,711,000. Cantor Fitzgerald L. P. lifted its holdings in ARYA Sciences Acquisition Corp V by 532.7% during the 3rd quarter. Cantor Fitzgerald L. P. now owns 632,668 shares of the company's stock worth $6,206,000 after buying an additional 532,668 shares in the last quarter. RiverPark Advisors LLC purchased a new stake in shares of ARYA Sciences Acquisition Corp V in the 4th quarter valued at approximately $3,808,000. Westchester Capital Management LLC increased its position in shares of ARYA Sciences Acquisition Corp V by 248.6% in the 3rd quarter. Westchester Capital Management LLC now owns 270,608 shares of the company's stock valued at $2,652,000 after purchasing an additional 192,972 shares during the last quarter. Finally, Bank of Montreal Can purchased a new stake in shares of ARYA Sciences Acquisition Corp V in the 3rd quarter valued at approximately $1,731,000. 70.45% of the stock is currently owned by institutional investors and hedge funds.

About ARYA Sciences Acquisition Corp V

ARYA Sciences Acquisition Corp V does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses in the healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in New York, New York.

Read More

• Get a free copy of the StockNews.com research report on ARYA Sciences Acquisition Corp V (ARYE)
• Should Medtronic's Recent Colibri Patent Controversy Concern You?
• Checkpoint Software Helps Cyber Security Stocks Bottom
• Under Armour Stock, Gap and Crap, Here's Why
• Is Chevron Positioned To Take Energy Sector Leadership?
• What Does the Consumer Price Index Measure?

Receive News & Ratings for ARYA Sciences Acquisition Corp V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARYA Sciences Acquisition Corp V and related companies with MarketBeat.com's FREE daily email newsletter.